Search

everythinglearnresearchcommunity

for

Search:↓

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Prolactin may be important for skin growth and immune function.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Targeting TGFβ can improve skin immunity in older people.

TLR4 is important in aging-related diseases and could be a new treatment target.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.